Valneva SE (VLS.PA)
VLS.PA on Paris Stock Exchange
4.73EUR
8:00pm IST
4.73EUR
8:00pm IST
Change (% chg)
€0.09 (+1.83%)
€0.09 (+1.83%)
Prev Close
€4.64
€4.64
Open
€4.67
€4.67
Day's High
€4.82
€4.82
Day's Low
€4.57
€4.57
Volume
392,717
392,717
Avg. Vol
337,006
337,006
52-wk High
€4.82
€4.82
52-wk Low
€1.78
€1.78
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2020 | Mar '20 | 35.22 | -0.013 |
| FY 2019 | Dec '19 | 71.68 | 0.006 |
| Sep '19 | 26.88 | -0.000 | |
| Jun '19 | 54.51 | -0.030 | |
| FY 2018 | Dec '18 | 34.71 | 0.079 |
| Sep '18 | 19.36 | -0.040 | |
| Jun '18 | 26.88 | -0.020 | |
| Mar '18 | 32.08 | 0.020 |
*Note: Units in Millions ofEuro
**Note: Units in Euro
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-20 | 1 | 20.78 | 20.78 | 20.78 | 24.80 |
| Quarter Ending Dec-20 | 1 | 36.60 | 36.60 | 36.60 | 42.60 |
| Year Ending Dec-20 | 6 | 113.86 | 118.00 | 111.00 | 141.54 |
| Year Ending Dec-21 | 8 | 153.13 | 190.10 | 107.30 | 154.95 |
| Earnings (per share) | |||||
| Quarter Ending Sep-20 | 1 | -0.16 | -0.16 | -0.16 | -0.06 |
| Quarter Ending Dec-20 | 1 | -0.11 | -0.11 | -0.11 | 0.06 |
| Year Ending Dec-20 | 6 | -0.40 | -0.20 | -0.56 | 0.03 |
| Year Ending Dec-21 | 6 | -0.38 | 0.20 | -1.05 | -0.35 |
Sales and Profit Figures in Euro (EUR);
Valuation Ratios
Dividends
Growth Rates
Financial Strength
Profitability Ratios
Efficiency
Management Effectiveness
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 20.04 | 45.65 | 55.75 |
| EPS (TTM) % | -132.43 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Valneva SE
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 1.04 | -3.61 | 99 | -- |
| 13 Week | 2.10 | -1.99 | 99 | -- |
| 26 Week | 18.70 | 13.72 | 99 | -- |
| 52 Week | 11.03 | -7.20 | 99 | -- |
| YTD | -5.50 | -14.27 | 99 | -- |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
- BRIEF-Valneva Partners With Batavia Biosciences For Polio Vaccine
- BRIEF-Valneva: Hart-Scott-Rodino Clearance For Lyme Vaccine Collaboration With Pfizer
- BRIEF-Valneva Publishes Phase 1 Data For Single-Shot Chikungunya Vaccine Candidate
- BRIEF-Valneva Confirms Repurchase Of About 18 Million Preferred Shares
- BRIEF-Valneva Q1 EBITDA Down At 2.4 Million Euros
Institutional Holders
| % Shares Owned: | 26.95% |
| # of Holders: | 30 |
| Total Shares Held: | 24,506,974 |
| 3 Mo. Net Change: | -771,893 |
| # New Positions: | 1 |
| # Closed Positions: | 1 |
| # Increased Positions: | 8 |
| # Reduced Positions: | 7 |
| # Net Buyers: | 1 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.